LONG TERM FOLLOW-UP OF PATIENTS WITH METASTATIC (M+) AND HIGH-RISK MEDULLOBLASTOMA WITH TAILORED-DOSES HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) CSI PLUS/MINUS HIGH-DOSE THIOTEPA.

Massimino, M.; Gandola, L.; Spreafico, F.; Biassoni, V.; Schiavello, E.; Pecori, E.; Pignoli, E.; Giandini, T.; Luksch, R.; Casanova, M.; Ferrari, A.; Terenziani, M.; Poggi, G.; Podda, M.; Meazza, C.; Catania, S.; Chiaravalli, S.; Puma, N.; Boschetti, L.; Veneroni, L.; Antonelli, M.; Buttarelli, F.; F. Giangaspero.,

LONG TERM FOLLOW-UP OF PATIENTS WITH METASTATIC (M+) AND HIGH-RISK MEDULLOBLASTOMA WITH TAILORED-DOSES HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) CSI PLUS/MINUS HIGH-DOSE THIOTEPA / M. M., G. L., S. F., B. V., S. E., P. E., P. E., G. T., L. R., C. M., A. Ferrari, T. M., P. G., P. M., M. C., C. S., C. S., P. N., B. L., V. L., A. M., B. F., G. F. - In: ATTI DEL 47th Congress of the International Society of Paediatric Oncology (SIOP)[s.l], 2015. (( convegno 47th Congress of the International Society of Paediatric Oncology (SIOP) tenutosi a Cape Town, South Africa nel 8-11 OTTOBRE 2015.